221 related articles for article (PubMed ID: 36407083)
1. Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma.
Wang S; Li Y; Liu N; Shen W; Xu W; Yao P
Genet Res (Camb); 2022; 2022():8566342. PubMed ID: 36407083
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
[TBL] [Abstract][Full Text] [Related]
3. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
[TBL] [Abstract][Full Text] [Related]
4. Integrating single-cell and bulk sequencing data to identify glycosylation-based genes in non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
Zhou Z; Gao Y; Deng L; Lu X; Lai Y; Wu J; Chen S; Li C; Liang H
PeerJ; 2024; 12():e17002. PubMed ID: 38515461
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of nonalcoholic fatty liver disease-associated hepatocellular carcinoma using SB transposon mutagenesis.
Kodama T; Yi J; Newberg JY; Tien JC; Wu H; Finegold MJ; Kodama M; Wei Z; Tamura T; Takehara T; Johnson RL; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2018 Oct; 115(44):E10417-E10426. PubMed ID: 30327349
[TBL] [Abstract][Full Text] [Related]
6. Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.
Frades I; Andreasson E; Mato JM; Alexandersson E; Matthiesen R; MartÃnez-Chantar ML
PLoS One; 2015; 10(5):e0124544. PubMed ID: 25993042
[TBL] [Abstract][Full Text] [Related]
7. Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease.
Fujiwara N; Kubota N; Crouchet E; Koneru B; Marquez CA; Jajoriya AK; Panda G; Qian T; Zhu S; Goossens N; Wang X; Liang S; Zhong Z; Lewis S; Taouli B; Schwartz ME; Fiel MI; Singal AG; Marrero JA; Fobar AJ; Parikh ND; Raman I; Li QZ; Taguri M; Ono A; Aikata H; Nakahara T; Nakagawa H; Matsushita Y; Tateishi R; Koike K; Kobayashi M; Higashi T; Nakagawa S; Yamashita YI; Beppu T; Baba H; Kumada H; Chayama K; Baumert TF; Hoshida Y
Sci Transl Med; 2022 Jun; 14(650):eabo4474. PubMed ID: 35731891
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
9. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Kunimoto H; Sorin Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
Hepatol Int; 2016 Jul; 10(4):647-56. PubMed ID: 27074850
[TBL] [Abstract][Full Text] [Related]
10. Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis.
Zhang G; Hou Y
World J Surg Oncol; 2022 Nov; 20(1):364. PubMed ID: 36397165
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
Dongiovanni P; Romeo S; Valenti L
World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
13. Identification of the Non-Alcoholic Fatty Liver Disease Molecular Subtypes Associated With Clinical and Immunological Features
Liu Z; Li Y; Yu C
Front Immunol; 2022; 13():857892. PubMed ID: 35958576
[TBL] [Abstract][Full Text] [Related]
14. Weighted Gene Co-Expression Network Analysis of Immune Infiltration in Nonalcoholic Fatty Liver Disease.
Wang Z; Xia Y; Pan Y; Zhang L; Tang F; Yu X; Yang Z; Wang D; Yang L; Jia J; Yuan G
Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1173-1185. PubMed ID: 36503447
[TBL] [Abstract][Full Text] [Related]
15. Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease.
Cai C; Song X; Yu C
Cancer Biomark; 2020; 29(1):69-78. PubMed ID: 32623384
[TBL] [Abstract][Full Text] [Related]
16. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
17. Predicting Non-Alcoholic Fatty Liver Disease Progression and Immune Deregulations by Specific Gene Expression Patterns.
Zeng F; Zhang Y; Han X; Zeng M; Gao Y; Weng J
Front Immunol; 2020; 11():609900. PubMed ID: 33574818
[TBL] [Abstract][Full Text] [Related]
18. A micro-RNA expression signature for human NAFLD progression.
Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
[TBL] [Abstract][Full Text] [Related]
19. Integrated single-cell transcriptomics reveals the hypoxia-induced inflammation-cancer transformation in NASH-derived hepatocellular carcinoma.
Liang Y; Zhang R; Biswas S; Bu Q; Xu Z; Qiao L; Zhou Y; Tang J; Zhou J; Zhou H; Lu L
Cell Prolif; 2024 Apr; 57(4):e13576. PubMed ID: 37994257
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
